New Drug to Control Pain Related to Cancer Treatment Originally Developed at Stony Brook Gets FDA Clearance
July 18, 2024
July 18, 2024
STONY BROOK, New York, July 18 (TNSres) -- The State University of New York's Stony Brook University issued the following news release:
* * *
The "FABP" inhibitor is part of a series of compounds that uses the body's natural marijuana-like substances to curb pain and inflammation
* * *
Six years ago Stony Brook University through the Research Foundation for the State University of New York licensed a promising technology to Artelo Bio . . .
* * *
The "FABP" inhibitor is part of a series of compounds that uses the body's natural marijuana-like substances to curb pain and inflammation
* * *
Six years ago Stony Brook University through the Research Foundation for the State University of New York licensed a promising technology to Artelo Bio . . .